Adhesion to inhaled treatment in patients with asthma and COPD Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002
Inhaled medication use in asthma and COPD Roma/Gypsies patients Source: Eur Respir J 2005; 26: Suppl. 49, 610s Year: 2005
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003
Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018 Year: 2018
Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients Source: Eur Respir J 2002; 20: Suppl. 38, 304s Year: 2002
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
When to give corticosteroid inhalation therapy in stable COPD Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001
Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001
ERS guideline on withdrawal of inhaled corticosteroids in COPD Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD Year: 2021
Withdrawal of ICS in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014
The influence of type of inhalation device on adherence of COPD patients to inhaled medication Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013
Low adherence to inhaled corticosteroids/long-acting ß2 -agonists and biologic treatment in severe asthmatics Source: ERJ Open Res, 6 (2) 00017-2020; 10.1183/23120541.00017-2020 Year: 2020
Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018
Differences in adherence to inhaled steroid medication in COPD Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011
Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Inhaled corticosteroid therapy on admission of hospitalized patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002
Inhaled antibiotic therapy in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021